We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NHI icon
851
National Health Investors
NHI
$3.4B
$1.25M 0.01%
19,920
+2,420
+14% +$149K
AMG icon
852
Affiliated Managers Group
AMG
$9B
$1.24M 0.01%
+6,046
New +$1.17M
AES icon
853
AES
AES
$10.6B
$1.24M 0.01%
79,800
-2,563,130
-97% -$36.8M
VRNT
854
DELISTED
Verint Systems
VRNT
$1.24M 0.01%
49,664
-27,482
-36% -$647K
BKS
855
DELISTED
Barnes & Noble
BKS
$1.24M 0.01%
82,862
+64,703
+356% +$780K
IVZ icon
856
Invesco
IVZ
$13.6B
$1.22M 0.01%
+32,286
New +$1.17M
SNX icon
857
TD Synnex
SNX
$21B
$1.22M 0.01%
33,400
-16,800
-33% -$564K
UEIC icon
858
Universal Electronics
UEIC
$65.5M
$1.21M 0.01%
24,800
+600
+2% +$24.8K
DBC icon
859
Invesco DB Commodity Index Tracking Fund
DBC
$2B
$1.21M 0.01%
45,382
+6,241
+16% +$164K
GPRE icon
860
Green Plains
GPRE
$1.04B
$1.2M 0.01%
36,600
+29,200
+395% +$859K
DEI icon
861
Douglas Emmett
DEI
$1.73B
$1.2M 0.01%
42,600
+28,300
+198% +$788K
SMP icon
862
Standard Motor Products
SMP
$839M
$1.2M 0.01%
26,800
– –
GTE icon
863
Gran Tierra Energy
GTE
$389M
$1.19M ﹤0.01%
14,623
-30,406
-68% -$2.24M
EWK icon
864
iShares MSCI Belgium ETF
EWK
$166M
$1.18M ﹤0.01%
68,797
– –
CLVS
865
DELISTED
Clovis Oncology, Inc.
CLVS
$1.18M ﹤0.01%
28,465
-1,145
-4% -$59K
TU icon
866
Telus
TU
$14.3B
$1.18M ﹤0.01%
+63,000
New +$1.15M
MDU icon
867
MDU Resources
MDU
$3.91B
$1.17M ﹤0.01%
87,365
+37
+0% +$483
HALO icon
868
Halozyme
HALO
$12.1B
$1.17M ﹤0.01%
117,961
-4,745
-4% -$40.3K
EPR icon
869
EPR Properties
EPR
$4.5B
$1.16M ﹤0.01%
20,700
-3,300
-14% -$179K
VRSN icon
870
VeriSign
VRSN
$26.9B
$1.14M ﹤0.01%
23,400
+1,500
+7% +$74.8K
VDE icon
871
Vanguard Energy ETF
VDE
$11.2B
$1.14M ﹤0.01%
7,900
– –
MSF
872
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
$1.12M ﹤0.01%
70,000
– –
CYH icon
873
Community Health Systems
CYH
$419M
$1.09M ﹤0.01%
29,190
-43,681
-60% -$1.45M
SLG icon
874
SL Green Realty
SLG
$3.67B
$1.09M ﹤0.01%
10,330
-3,099
-23% -$320K
MMSI icon
875
Merit Medical Systems
MMSI
$5.15B
$1.09M ﹤0.01%
72,345
+58,345
+417% +$808K
33 34
35
36 37

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.